← FDA MEDWATCH
FDA (US) · FDA PRESS RELEASEAugust 6, 2026
FDA Approves New Engineered Viral Immunotherapy for Patients with Treatment-Resistant Advanced Melanoma
What this record is not
Item details are published by the U.S. FDA on fda.gov; SPEQ surfaces them for reference and is not affiliated with or endorsed by the FDA. The authoritative notice is on fda.gov.
Item type
FDA Press Release
Published
August 6, 2026
Source
U.S. FDA (MedWatch / press releases)
READ THE FULL FDA NOTICE
The complete FDA notice — the affected products, the action required, and any recall detail — is published on fda.gov. SPEQ surfaces and indexes it for reference; the authoritative notice lives on fda.gov.
View on fda.gov →